• Opinion
• [Reporter’s View]Year of regulations, principle vs practice
• by Kim, Jin-Gu Jan 5, 2022 05:57am

• Company
• Exports of the biohealth industry surpassed 19 trillion won
• by Jan 5, 2022 05:57am

• Policy
• Combination drugs of PPI+ antacid have also been released
• by Lee, Tak-Sun Jan 5, 2022 05:57am

• Company
• Only 14% of Pharmas plan to increase jobs due to COVID-19
• by Chon, Seung-Hyun Jan 4, 2022 05:56am

• Policy
• Recovery Action held by the Legislation/Judiciary Committee
• by Lee, Jeong-Hwan Jan 4, 2022 05:56am

• Policy
• President Moon "will make all efforts to return to normalcy"
• by Lee, Jeong-Hwan Jan 4, 2022 05:56am

• Company
• 2/3 of CEOs plan to continue 'contactless' business activity
• by Kim, Jin-Gu Jan 4, 2022 05:56am

• Policy
• Minister Kwon said he would develop vaccines and txs
• by Kim, Jung-Ju Jan 4, 2022 05:55am

• Policy
• Additional contracts for COVID-19 PO tx are under discussion
• by Kim, Jung-Ju Jan 4, 2022 05:55am

• Company
• Strengthening sales is the top priority in competitiveness
• by Chon, Seung-Hyun Jan 3, 2022 05:57am